Fig. 2
From: Overexpression of MCL-1 in canine hepatocellular carcinoma and its efficacy as a prognostic marker
MCL-1 immunoreactivity in canine representative liver tissues. (A, B) HCC tissues demonstrating high MCL-1 immunostaining. (C) Non-neoplastic hepatic disease tissue demonstrating low MCL-1 immunostaining. (D) Normal canine liver tissue. (E) Positive control; MCL-1 expression in canine MGT tissue. (F) Negative control; no specific immunostaining was detected in normal liver tissue. (A-F: 400X magnification). Abbreviations: MCL-1, myeloid Cell Leukemia-1; HCC, hepatocellular carcinoma; MGT, mammary gland tumor